Abstract
Introduction
Spinal muscular atrophy (SMA) is a common neuromuscular disorder, recognized as the most prevalent genetic cause of early childhood mortality (Pearn 1980) . Patients with the most severe form of the disease, which is also the most common, become symptomatic in the first six months of life and rarely live past two years (Wee et al. 2010; Prior 2010) .
Because the onset of symptoms and their severity can vary, SMA has historically been classified into three subtypes (Ogino and Wilson 2004) . More recently, clinicians have recognized that SMA is better characterized as a continuous spectrum disorder, ranging from acute (prenatal onset) to nearly asymptomatic (Tiziano et al. 2013) . Clinically, SMA patients experience degeneration of motor neurons in the anterior horn of the lower spinal cord (Crawford and Pardo 1996) . This leads to progressive atrophy of proximal muscle groups, ultimately resulting in loss of motor function and symmetrical paralysis.
The cause of death is often restrictive respiratory failure (Kolb and Kissell 2015) .
SMA typically results from homozygous deletion of the survival motor neuron 1 (SMN1) gene (Lefebvre et al. 1995) . A small fraction of SMA patients have lost one copy of SMN1 and the remaining copy contains a point mutation (Burghes and Beattie 2009).
Humans have two SMN paralogs, named SMN1 and SMN2, both of which contribute to total cellular levels of SMN protein. SMN2 exon 7 contains a silent base change that alters splicing to primarily produce a truncated, unstable protein product called SMN∆7 Monani et al. 1999; Lorson and Androphy 2000) . The last 16 amino acids of SMN are replaced in SMNΔ7 by four amino acids, EMLA, encoded by exon 8.
Current estimates suggest that SMN2 produces 10-15% of the level of full-length protein produced by SMN1 (Lorson et al. 2010) . Complete loss of SMN is lethal in all organisms investigated to date (Schrank et al. 1997; Monani 2005) . Although the amount of fulllength protein produced by SMN2 is not enough to compensate for loss of SMN1, SMN2 is sufficient to rescue embryonic lethality (Monani et al. 2000) . SMA is therefore a disease that arises due to a hypomorphic reduction in SMN levels (Lefebvre et al. 1995) .
Furthermore, relative levels of the SMN protein correlate with the phenotypic severity of Wang 2014; Li et al. 2014) . The best-characterized function of this complex, which is found in all tissues of metazoan organisms, is in the cytoplasmic assembly of small nuclear ribonucleoproteins (snRNPs), core components of the spliceosome (Fischer et al. 1997; Meister et al. 2001; Pellizzoni et al. 2002) .
Although it is ubiquitously expressed, SMN has also been implicated in a number of tissue-specific processes related to neurons and muscles. These functions include actin dynamics (Oprea et al. 2008; Ackermann et al. 2013) , axonal pathfinding (Fan and Simard 2002; McWhorter et al. 2003; Sharma et al. 2005) , axonal transport of β-actin mRNP (Rossoll et al. 2003) , phosphatase and tensin homolog-mediated (PTENmediated) protein synthesis pathways , translational regulation (Sanchez et al. 2013) , neuromuscular junction formation and function (Chan et al. 2003; Kariya et al. 2008; Kong et al. 2009; Voigt et al. 2010) , myoblast fusion (Shafey et al. 2005 ) and maintenance of muscle architecture (Rajendra et al. 2007; Walker et al. 2008; Bowerman et al. 2009 ).
Ubiquitylation pathways have been shown to regulate the stability and degradation of SMN (Chang et al. 2004; Burnett et al. 2009; Hsu et al. 2010) as well as axonal and synaptic stability (Korhonen and Lindholm 2004) . In the ubiquitin proteasome system (UPS), proteins destined for degradation are tagged by linkage to ubiquitin through the action of three factors (Petroski 2008) . E1 proteins activate ubiquitin and transfer it to the E2 enzyme. E2 proteins conjugate ubiquitin to their substrates. E3 proteins recognize the substrate and assist in the transfer of ubiquitin from the E2. Because E3 ligases confer substrate specificity, they are typically considered as candidates for targeted inhibition of protein degradation. Ubiquitin homeostasis is thought to be particularly important for neuromuscular pathology in SMA (Groen and Gillingwater 2015) . Indeed, mouse models of SMA display widespread perturbations in UBA1 (ubiquitin-like modifier activating enzyme 1) levels (Wishart et al. 2014) . Furthermore, mutations in UBA1 are known to cause X-linked infantile SMA (Ramser et al. 2008; Schmutzler et al. 2008) .
Given the importance of these processes to normal development as well as neurodegenerative disease, we set out to identify and characterize novel SMN binding partners. Previously, we developed Drosophila as a model system wherein the endogenous Smn gene is replaced with a Flag-Smn transgene (Praveen et al. 2012) .
When expressed in the fly, SMA-causing point mutations recapitulate the full range of . CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/078337 doi: bioRxiv preprint first posted online  phenotypic severity seen in humans (Praveen et al. 2014; Garcia et al. 2016) . Using this system, we carried out proteomic profiling of Flag-purified embryonic lysates and identified the SCF Slmb E3 ubiquitin ligase complex as a novel SMN interactor. Importantly, this interaction is conserved from flies to humans. We show that SCF Slmb binding requires a phospho-degron motif located within the SMN self-oligomerization domain, whose mutation stabilizes both SMN∆7 and full-length SMN. Additional studies in flies, mice and human cells elucidate a disease-relevant mechanism whereby SMN protein stability is regulated by self-oligomerization.
Results

Flag-SMN interacts with UPS (ubiquitin proteasome system) proteins
We previously generated transgenic Drosophila melanogaster that express Flag-tagged SMN proteins in an otherwise null Smn background (Praveen et al. 2012) . To preserve endogenous expression patterns, the constructs are driven by the native promoter and flanking sequences. We collected (0-12h) embryos from Flag-Smn WT (SMN) and Oregon-R (Ctrl) animals and analyzed Flag-purified lysates by 'label-free' mass spectrometry. In addition to Flag-SMN, we identified SMN complex components Gemin2 and Gemin3, along with all seven of the canonical Sm-core snRNP proteins (Fig. 1A) . We also identified the U7-specific Sm-like heterodimer Lsm10/11 (Pillai et al. 2003 ) and the Gemin5 orthologue, Rigor mortis (Gates et al. 2004) . Previous studies of Schneider2 (S2) cells transfected with epitope-tagged Smn had identified most of the proteins listed above as SMN binding partners in Drosophila (Kroiss et al. 2008) . However, despite bioinformatic (Kroiss et al. 2008 ) and cell biological (Cauchi et al. 2010 ) data indicating that Rigor mortis is part of the fruit fly SMN complex, this protein failed to co-purify with SMN in S2 cells (Kroiss et al. 2008; Guruharsha et al. 2011) . On the basis of these data, we conclude that our purification conditions are effective and that Rigor mortis/Gemin5 is an integral member of the SMN complex in flies.
In addition to SMN complex members, we also co-purified numerous factors that are part of the ubiquitin proteasome system (UPS; Fig. 1B ). Among these UPS proteins, we identified Cullin 1 (Cul1), Skp1-related A (SkpA), and supernumerary limbs (Slmb), as being highly enriched (>10 fold) in Flag-SMN samples as compared to the controls.
Together, these proteins comprise the SCF Slmb E3 ubiquitin ligase. Cul1 forms the major structural scaffold of this horseshoe-shaped, multi-subunit complex (Zheng et al. 2002) .
Slmb is a F-box protein and is the substrate recognition component (Jiang and Struhl 1998) . SkpA is a bridging protein essential for interaction of Cul1 with the F-box protein (Patton et al. 1998a; Patton et al. 1998b) . Because of its role in substrate recognition, Slmb is likely to be the direct interacting partner of SMN within the SCF Slmb complex. For this reason, we focused on Slmb for the initial verification. As shown, Slmb was easily detectable in Flag-purified eluates from embryos expressing Flag-SMN and nearly undetectable in those from control embryos (Fig. 1C) .
SCF
Slmb is a bona fide SMN protein interaction partner
The interaction of SCF Slmb with SMN was further verified in a reciprocal coimmunoprecipitation demonstrating that Flag-tagged SCF components form complexes with Myc-SMN and endogenous SMN in S2 cells ( Fig. 2A) . We also tested SMN interaction with Roc1a, a RING domain protein known to interact with Cul1 (Noureddine et al. 2002) . SMN was clearly detected following immunoprecipitation of Cul1-Flag and Flag-Slmb ( Fig. 2A) , and we also detected slightly above background levels after immunoprecipitation of Flag-Roc1a and SkpA-Flag. Notably, when probed with anti-SMN antibodies, Flag-Slmb reproducibly co-precipitates four higher molecular weight species of SMN (Fig. 2B ). The steps of the ladder are separated by ~8kDa, which is very close to the MW of ubiquitin. Furthermore, this ladder is not visible following immunoprecipitation by Gemin2 or any of the other SCF Slmb components, which are not expected to be direct binding partners of ubiquitylated SMN. These findings suggest that Slmb associates with mono-, di-, tri-, and tetra-ubiquityltated SMN isoforms.
7
The SCF complex is highly conserved from flies to humans: SkpA is 77% identical to human Skp1, Cul1 is 63% identical, and Slmb is 80% identical to its human homologs, B-TrCP1 and B-TrCP2. We therefore tested the interaction of Flag-tagged Drosophila SCF components with endogenous human SMN in HEK 293T cells (Fig. 2C) .
Accordingly, human SMN was co-precipitated with Flag-Cul1 and Flag-Slmb and at lower levels following Flag-SkpA immunoprecipitation. Finally, we detected interaction of Flag-B-TrCP1 and Flag-B-TrCP2, the two human homologs of Slmb, with endogenous human SMN in HEK 293T cells (Fig. 2D) . Altogether, these data demonstrate a conserved interaction between SMN and the SCF Slmb/B-TrCP E3 ubiquitin ligase complex.
Depletion of Slmb/B-TrCP results in modest increase of SMN levels
Given that one of the primary functions of protein ubiquitylation is to target proteins to the proteasome for degradation, we examined whether depletion of Slmb by RNAi using dsRNA in S2 cells would result in increased SMN levels (Fig. 3A) . Following Slmb RNAi, endogenous SMN levels were modestly increased as compared to cells treated with control dsRNA. We obtained similar results using an siRNA that targets both B-TrCP1
and B-TrCP2 in HeLa cells. As shown in Fig. 3B , we detected a modest increase in levels of full-length SMN following B-TrCP RNAi, but not control RNAi. Next, we treated S2 cells with cycloheximide (CHX), in the presence or absence of dsRNA targeting Slmb, to determine whether differences in SMN levels would be exacerbated when production of new proteins was prevented (Fig. 3C ). At 6 hours post-CHX treatment there is a modest increase in full-length SMN levels following Slmb RNAi as compared to the initial timepoint (0h) or the negative control (Osk) RNAi (Fig. 3C ). Together, these data indicate that Slmb/B-TrCP participates in the regulation of SMN protein levels. 4A ). This construct is fully functional in vivo (see below). We then generated serine to alanine mutations in both the full-length (vSmnS201A) and truncated (vSmnΔ7A) versions of the protein.
Identification and characterization of a Slmb/B-TrCP degradation signal in SMN
To test the effects of overall protein length and distance of the putative degron from the C-terminus, we also generated SMN constructs that are the same length as SMNΔ7, replacing MEMLA* (the amino acids introduced by human SMN2 splicing) with MGLRQ*, see Fig. 4A . The S201A mutation was created in this construct as well (MGLRQ* S201A ). To mimic a constitutively phosphorylated state, we also generated vSmn S201D and vSmn∆7D. We transfected each of these constructs, Flagtagged and driven by the native Smn promoter, into S2 cells and measured protein levels by western blotting (Fig. 4B ). As shown, the constructs that contain the S201A mutation exhibited increased protein levels whereas those of the S201D mutants were comparable or slightly reduced, suggesting that the phospho-degron motif identified in human SMN∆7 (Cho and Dreyfuss 2010) is also conserved in the fly protein.
We note that the MGLRQ* construct is present at levels that are similar to wild-type (vSmn) and much higher than vSmnΔ7S. Based on the crystal structures of the SMN YG box (Martin et al. 2012; Gupta et al. 2015) , the presence of the MGLR insertion in Drosophila SMN is predicted to promote self-oligomerization (A.G.M. and G.D. Van Duyne, unpublished), thus stabilizing the protein within the SMN complex (Burnett et al. 2009 ). By the same logic, the relative inability of vSmnΔ7S to self-interact would be predicted to lead to its destruction. To determine whether the observed increase in SMN protein levels correlated with its ability to interact with Slmb, we co-transfected the appropriate Flag-Smn constructs with Myc-Slmb in S2 cells. Protein lysates were then . CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/078337 doi: bioRxiv preprint first posted online  Flag-immunoprecipitated and probed with anti-Myc antibody (Fig. 4C ). The S201A mutation decreased binding of Slmb to both the full-length and the truncated SMN isoforms (Fig. 4C) . However, the vSmn∆7S construct co-precipitated the greatest amount of Slmb protein, despite the fact that it is present at much lower levels in the input lysate (Fig. 4C ). Because SMN∆7 is defective in self-interaction, this result suggests that the degron is more accessible to Slmb when SMN is monomeric and cannot efficiently oligomerize.
SMN self-oligomerization regulates access to the Slmb degron
To examine the connection between SMN self-oligomerization and degron accessibility more closely we took advantage of two YG box point mutations (Y203C and G206S) that are known to destabilize the full-length protein and to decrease its self-oligomerization capacity (Praveen et al. 2014) . As a control, we also employed a mutation (G210V) that does not disrupt self-oligomerization (Praveen et al. 2014; Gupta et al. 2015) . Next, we introduced the S201A mutation into all three of these full-length SMN constructs, transfected them into S2 cells and carried out western blotting to detect levels of each transfected construct (Fig. 5A ). As quantified in Fig. 5B , the S201A degron mutation has a clear stabilizing effect on the G206S and Y203C constructs, as compared to the effect of S201A paired with G210V. Hence, we conclude that the Slmb degron is exposed when SMN is present predominantly as a monomer, whereas it is less accessible when the protein is able to form higher order multimers.
SMN∆7A is a protective modifier of intermediate SMA phenotypes
Increased SMN2 copy number, and therefore increased SMNΔ7 protein, correlates with a milder clinical phenotype in SMA patients (Wirth 2000) . This phenomenon was successfully modeled in mice over a decade ago (Monani et al. 2000; Hsieh-Li et al. 2000) , showing that high copy number SMN2 transgenes fully rescue the null phenotype, whereas low copy transgenes do not. Moreover, transgenic expression of a human SMN∆7 cDNA construct in a low-copy SMN2 background improves survival of this severe SMA mouse model from P5 (post-natal day 5) to P13 .
Experiments in an SMN-deficient DT40 cell line showed that expression of SMNΔ7A, but not SMN∆7S, rescued cellular proliferation (Cho and Dreyfuss 2010) , demonstrating that SMN∆7A is at least partially functional.
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The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/078337 doi: bioRxiv preprint first posted online  To examine whether expression of SMN∆7A could rescue animal development, we generated flies carrying Flag-tagged vSmn∆7A and vSmnS201A transgenes in an otherwise null Smn background. As shown in Fig. S1 , levels of vSmn∆7A were very low, and that of the vSmn∆7S transgene was barely detectable in comparison to the fulllength constructs. Levels of vSmn and vSmn S201A were comparable and, as expected, both transgenes produce fully viable and fertile adults (Fig. 6A ). In fact, the eclosion frequencies of animals expressing Flag-vSmn or -vSmn S201A are higher than those of wild-type Flag-Smn ( Fig. 6A and Praveen et al. 2012; Praveen et al. 2014) . In contrast,
neither Flag-vSmn∆7S nor -vSmn∆7A was able to rescue viability of the Smn null allele; these animals also died as late 2 nd or early 3 rd instar larvae. We crossed the FlagvSmn∆7S nor -vSmn∆7A transgenes with Smn alleles of varying severity, as determined by protein levels (Praveen et al. 2014) . These include, in order of decreasing severity: a V72G point mutant (V72G), a wild-type Flag-Smn line that expresses lower than endogenous levels of SMN (WT), and a balancer chromosome (+) that expresses normal levels of SMN. When crossed to each of these allelic combinations (Fig. 6B) , the constructs did not provide a protective benefit. Thus, we conclude that transgenic expression of Flag-vSMN∆7A is not sufficient for fruit fly development, at least when expressed using the native promoter (Fig. 6C ).
To examine the importance of the Slmb degron in a mammalian system, two previously developed SMA mouse models were utilized. As mentioned above, the 'Delta7' mouse (Smn −/− ;SMN2;SMNΔ7), is a model of severe SMA , and affected pups usually die between P10 and P18 (Avg. P15). The '2B/-' mouse (Smn 2B/-) is a model of intermediate SMA (Bowerman et al. 2012; Rindt et al. 2015) and these animals survive much longer before dying, typically between P25 and P45 (Avg. P32). Adeno-associated virus serotype 9 (AAV9) was selected to deliver the SMN cDNA isoforms to these SMA mice, as this vector has previously been shown to enter and express in SMA-relevant tissues and can dramatically rescue the SMA phenotype when expressing the wild-type SMN cDNA (Foust et al. 2010; Passini et al. 2010; Valori et al. 2010; Dominguez et al. 2011; Glascock et al. 2012) .
. CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/078337 doi: bioRxiv preprint first posted online  Delivery of AAV9-SMNΔ7A at P1 significantly extended survival in the intermediate 2B/-animals, resulting in 100% of the treated pups living beyond 100 days, similar to the results obtained with the full-length AAV9-SMN construct (Fig. 7A) . In contrast, untreated 2B/-animals lived, on average, only 30 days. Mice treated with AAV9-SMNΔ7S survived an average of 45 days (Fig. 7A) . Interestingly, mice treated with AAV9-SMNΔ7D, a phosphomimetic of the wild-type serine 270 residue, have an average life span that is equivalent or slightly shorter than that of untreated 2B/-mice (Fig. 7A) . These results not only highlight the specificity of the S270A mutation in conferring efficacy to SMN∆7, but also illustrate that AAV9-mediated delivery of protein alone does not improve the phenotype.
We also analyzed the effects of SMN∆7A expression in the severe Delta7 mouse model . Treatment with AAV9-SMN∆7A had only a very modest effect on Delta7 mice, as none of the animals (treated or untreated) survived weaning (Fig. S2) . These findings are similar to the results in Drosophila, upon transgenic expression of SMN∆7A in the Smn null background (Fig. 6B ). Thus expression of SMN∆7A provides a clear protective benefit to the viability of intermediate mice, but not to severe SMA models.
Consistent with the lifespan data, AAV9-SMNΔ7A treated 2B/-mice gained significantly more weight than either untreated or AAV-SMNΔ7S treated animals, nearly achieving the same weight as pups treated with full-length SMN cDNA (Fig. 7B) . Treatment with full-length SMN cDNA resulted in animals that were clearly stronger and more mobile, consistent with the weight data (Fig. 7C ). Although they did not perform as well as mice treated with full-length SMN cDNA, the SMNΔ7A treated animals retained strength and gross motor function at late time points (e.g. P100), as measured by their ability to splay their legs and maintain a hanging position using a modified tube-test, (Fig. 7C ). Animals treated with AAV9-SMN∆7D and -SMN∆7S did not survive long enough for testing.
Finally, to examine the functionality of SMNΔ7A in disease-relevant human tissue, control and SMA induced pluripotent stem cell (iPSC) motor neuron cultures were transduced with lentiviral vectors expressing SMNΔ7A or an mCherry control (Figs.
7D,E). At 4 weeks post-differentiation, no statistical difference was observed between control and SMA motor neurons, however by 6 weeks, SMA motor neuron numbers had . CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/078337 doi: bioRxiv preprint first posted online  decreased significantly to approximately 7% of the total cell population (Fig. 7D) . In contrast, expression of SMNΔ7A maintained motor neuron numbers to approximately the same level as the controls, and nearly two-fold greater than untreated cells (Fig. 7D ).
Thus expression of SMN∆7A improves survival of human iPSCs when differentiated into motor neuron lineages.
Discussion
Factors that recognize the putative SMN∆7-specific degron have not been identified and the molecular mechanisms governing proteasomal access to SMN and SMN∆7 remain unclear. In this study, we isolated factors that co-purifiy with SMN from Drosophila embryos that exclusively express Flag-SMN. This approach reduces potential bias towards SMN partner proteins that may be more abundant in a given tissue or cell line (Charroux et al. 1999; Meister et al. 2001; Pellizzoni et al. 2002; Kroiss et al. 2008; Trinkle-Mulcahy et al. 2008; Guruharsha et al. 2011) . Because the entire reading frame of fruitfly Smn is contained within a single exon, only full-length SMN protein is expressed in flies (Rajendra et al. 2007 , a phosphomimetic, is a protective modifier of SMA phenotypes in animal models and human iPSC cultures.
The SCF Slmb degron is exposed by SMN2 exon skipping A previous study posited that a degron was specifically created by exon 7 skipping and that this event represented a key aspect of the SMA disease mechanism (Cho and Dreyfuss 2010) . Our identification of a putative Slmb binding site (phospho-degron) located in the C-terminal self-oligomerization domain of SMN has allowed us to explore the molecular details of this hypothesis. The mutation of a conserved serine within the Slmb degron not only disrupted the interaction between SMN and Slmb, but also stabilized full-length SMN and SMN∆7. Notably, the degron mutation has a greater effect 30, 2016; on SMN levels (both full-length and ∆7) when made in the context of a protein that does not efficiently self-oligomerize. These and other findings strongly suggest that the Slmb degron is uncovered when SMN is monomeric, whereas it is less accessible when SMN forms higher-order multimers. On the basis of these results, we conclude that SMN2 exon skipping does not create a potent protein degradation signal; rather, it exposes an existing one.
SMN may be targeted by multiple E3 ubiquitin ligases
SMN degradation via the UPS is well-established (Chang et al. 2004; Burnett et al. 2009; Kwon et al. 2011) . Accordingly, investigators have studied other E3 ligases that likely target SMN for degradation. Using a candidate approach, mind bomb 1 (Mib1) was shown to interact with and ubiquitylate SMN to facilitate its degradation in cultured human cells (Kwon et al. 2013) . It is therefore likely that SMN is targeted by multiple E3 (Tan et al. 2007; Kirkin et al. 2009; Lim and Lim 2010) . Interestingly, recent work has implicated defects in endocytosis in SMA (Custer and Androphy 2014; Dimitriadi et al. 2016; Hosseinibarkooie et al. 2016) . It remains to be determined how the ubiquitylation status of SMN might intersect with endocytic functions.
. 30, 2016; In the Flag-SMN pulldown, we identified three E2 proteins as potential SMN interacting partners (Fig. 1B) . Among them, Bendless (Ben) is particularly interesting because SMN co-purifies with Flag-Ben in S2 cells (Fig. S3) . Ube2N, the human ortholog of Ben, heterodimerizes with Uev1a to form K63 ubiquitin linkages ( 
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Phosphorylation of the Slmb degron within SMN
As Slmb is known to recognize phospho-degrons, one of the first questions raised by our study concerns the identity of the kinase(s) responsible for phosphorylating the degron in SMN. A prime candidate is GSK3B, as this kinase recognizes a motif (SxxxS/T; Liu et al.
2007
; Lee et al. 2013 ) that includes the degron and extends N-terminally ( 262 SxxxSxxxSxxxT 274 , numbering as per human SMN). In support of this hypothesis, we identified the Drosophila GSK3B orthologue, Shaggy (Sgg), in our SMN pulldowns (Fig.   1B) . Moreover, GSK3B inhibitors as well as siRNA mediated knockdown of GSK3B were .
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The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/078337 doi: bioRxiv preprint first posted online  shown to increase SMN levels, primarily by stabilizing the protein (Makhortova et al. 2011; Chen et al. 2012) . Finally, GSK3B is also responsible for phosphorylation of a degron in β-catenin, a well-characterized SCF Slmb substrate (Liu et al. 2002) . SMA mice have low levels of UBA1 (E1) ultimately leading to accumulation of β-catenin (Wishart et al. 2014) . Pharmacological inhibition of β-catenin improved neuromuscular pathology in Drosophila, zebrafish, and mouse SMA models. β-catenin had previously been shown to regulate motor neuron differentiation and stability primarily through affecting synaptic structure and function (Murase et al. 2002; Li et al. 2008; Ojeda et al. 2011 ). Betacatenin also regulates motor neuron differentiation by retrograde signaling from skeletal muscle (Li et al. 2008 ). The connections of UBA1 and multiple SCF Slmb substrates to motor neuron health thus places the UPS at the center of SMA research interest. All together, these findings strongly suggest that signaling cascades involving GSK3 act to regulate SMN levels in both humans and flies.
Conclusions
In summary, this study identifies conserved factors that regulate SMN stability. To our knowledge, this work represents the first time that SMN complexes have been purified in the context of an intact developing organism. Using this approach, we have demonstrated that the SCF Slmb E3 ligase complex interacts with a degron embedded within the self-oligomerization domain of SMN. Our findings establish plausible connections to disease-relevant cellular processes and signaling pathways. Further, they elucidate a model whereby accessibility of the SMN phospho-degron is regulated by selfmultimerization, providing an elegant mechanism for balancing functional activity with degradation.
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Experimental procedures
Fly stocks and genetics
Oregon-R was used as the wild-type control allele. The Smn X7 microdeletion allele (Chang et al. 2008 ) was a gift from S. Artavanis-Tsakonis (Harvard University, Cambridge, USA). This deficiency removes the promoter and the entire SMN coding region, leaving only the final 44bp of the 3' UTR. All stocks were cultured on molasses and agar at room temperature (24 ± 1°C) in half-pint bottles. The WT transgene construct was injected into embryos by BestGene Inc. (Chino Hills, CA).
SMN constructs
A ~3kb fragment containing the entire Smn coding region was cloned from the Drosophila genome into the pAttB vector (Bischof et al. 2007) . A 3X FLAG tag was The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/078337 doi: bioRxiv preprint first posted online  consecutive times with one bed volume of elution buffer (Tris 20mM pH 8, 100 mM KCl, 10% glycerol, 0.5 mM DTT, PMSF 0.2 mM) containing 250ug/mL 3XFLAG peptide (sigma). The entire eluate was used for mass spectrometry analysis on an Orbitrap Velos instrument, fitted with a Thermo Easy-spray 50cm column. 
Cycloheximide Treatment
Following RNAi treatment, S2 cells were pooled, centrifuged and resuspended in fresh media. 1/3 of these cells were frozen and taken as the 0h timepoint. The remainders of .
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Immunoprecipitation
Clarified cell lysates were precleared with immune-globulin G (IgG) agarose beads for 1h at 4C and again precleared overnight at 4C. The precleared lysates were then incubated with Anti-FLAG antibody crosslinked to agarose beads (EZview Red Anti-FLAG M2 affinity gel, Sigma) for 2h at 4C with rotation. The beads were washed with lysis buffer or modified lysis buffer six times and boiled in SDS gel-loading buffer. Eluted proteins were run on an SDS-PAGE for western blotting.
Antibodies and Western blotting
Larval and adult lysates were prepared by crushing the animals in lysis buffer (50mM Tris-HCl, pH 7.5, 150 mM NaCl, 1mM EDTA, 1% NP-40) with 1X (adults) or 10x (larvae) protease inhibitor cocktail (Invitrogen) and clearing the lysate by centrifugation at 13,000 RPM for 10 min at 4ºC. S2 cell lysates were prepared by suspending cells in lysis buffer (50mM Tris-HCl, pH 7.5, 150 mM NaCl, 1mM EDTA, 1% NP-40) with 10% glycerol and 1x protease inhibitor cocktail (Invitrogen) and disrupting cell membranes by pulling the suspension through a 25 gauge needle (Becton Dickinson). The lysate was then cleared by centrifugation at 13,000 RPM for 10 min at 4ºC. Human cells (293Ts and HeLas) were first gently washed in ice-cold 1X PBS, then collected in ice-cold 1X PBS by scraping. Cells were pelleted by spinning at 1000 rpm for 5 min. The supernatant was removed and cells were resuspended in ice cold lysis buffer (50mM Tris-HCl, pH 7.5, 150 mM NaCl, 1mM EDTA, 1% NP-40) and allowed to lyse on ice for 30 min. After lysing, the lysate was cleared by centrifuging the cells for 10 min at 13000 at 4C.
Western blotting on lysates was performed using standard protocols. Rabbit anti-dSMN serum was generated by injecting rabbits with purified full-length dSMN protein (Pacific Immunology Corp, CA), and was subsequently affinity purified. For Western blotting, dilutions of 1 in 2,500 for the affinity purified anti-dSMN, 1 in 20,000 (fly) or 1 in 5,000 (human) for anti-α tubulin (Sigma), 1 in 10,000 for monoclonal anti-Flag (Sigma), 1 in 1,000 for anti-Slmb (gift from Greg Rogers), 1 in 2,500 for anti-human SMN (BD Biosciences), 1 in 1,000 for anti-B-TrCP (gift from MB Major lab), and 1 in 10,000 for polyclonal anti-Myc (Santa Cruz) were used.
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Human iPSC Cell culture
Human iPSCs from two independent unaffected control and two SMA patient lines were grown as pluripotent colonies on Matrigel substrate (Corning) in Nutristem medium (Stemgent). Colonies were then lifted using 1mg/ml Dispase (Gibco) and maintained as floating spheres of neural progenitor cells in the neural progenitor growth medium Stemline (Sigma) supplemented with 100ng/ml human basic fibroblast growth factor (FGF-2, Miltenyi), 100ng/ml epidermal growth factor (EGF, Miltenyi), and 5µg/ml heparin (Sigma-Aldrich) in ultra-low attachment flasks. Aggregates were passaged using a manual chopping technique as previously described (Svendsen et al. 1998; Ebert et al. 2013 ). To induce motor neuron differentiation, neural progenitor cells were cultured in neural induction medium (1:1 DMEM/F12 (Gibco), 1x N2 Supplement (Gibco), 5µg/mL Heparin (Sigma), 1x Non-Essential Amino Acids (Gibco), and 1x Antibiotic-Antimycotic (Gibco)) plus 0.1µM all-trans retinoic acid (RA) for two weeks; 1µM Purmorphamine (PMN, Stemgent) was added during the second week. Spheres were then dissociated with TrypLE Express (Gibco) and plated onto Matrigel-coated 12mm coverslips in NIM plus 1µM RA, 1µM PMN, 1x B27 Supplement (Gibco), 200ng/mL Ascorbic Acid (Sigma), 1µM cAMP (Sigma), 10ng/mL BDNF (Peprotech), 10ng/mL GDNF (Peprotech)). One week post-plating, cells were infected with lentiviral vectors (MOI = 5) expressing mCherry alone or SMN S270A-IRES-mCherry. Transgenes in both viruses were under the control of the EF1α promoter. Uninfected cells served as controls. Cells were analyzed at 1 and 3 weeks post-infections, which was 4 and 6 weeks of total differentiation (Ebert et al. 2009; Sareen et al. 2013) .
Immunocytochemistry
Coverslips were fixed in 4% paraformaldehyde (Electron Microscopy Sciences) for 20 minutes at room temperature and rinsed with PBS. Cells were blocked with 5% Normal Donkey Serum (Millipore) and permeabilized in 0.2% TritonX-100 (Sigma) for 30 minutes at room temperature. Cells were then incubated in primary antibody solution for 1 hour, rinsed with PBS, and incubated in secondary antibody solution for 1 hour at room temperature. Finally, nuclei were labeled with Hoechst nuclear stain (Sigma) to label DNA and mounted onto glass slides using FluoroMount medium (SouthernBiotech).
Primary antibodies used were mouse anti-SMI-32 (Covance SMI-32R, 1:1000) and rabbit anti-mCherry (ThermoFisher, 1:1000). Secondary antibodies used were donkey . CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/078337 doi: bioRxiv preprint first posted online  anti-rabbit Cy3 (Jackson Immunoresearch 711-165-152) and donkey anti-mouse AF488 (Invitrogen A21202).
Immunocytochemical Analysis
Images were acquired from five random fields per coverslip using an inverted fluorescent microscope (Nikon) and NIS Elements software. Images were blinded and manually analyzed for antigen specificity with NIS Elements software. Identification of a conserved putative Slmb phospho-degron (DpSGXXpS/T motif variant) in the C-terminal self-oligomerization domain (YG Box) of SMN. To generate a more vertebrate-like SMN, key amino acids in Drosophila SMN were changed to amino acids conserved in vertebrates. Using this SMN backbone, a serine to alanine mutation was made in the putative degron in both full-length (vSMNS201A) and truncated SMNΔ7 (vSMNΔ7A). An additional SMN construct that is the same length as SMNΔ7, but has the amino acid sequence GLRQ (the next amino acids in the sequence) rather than EMLA (the amino acids introduced by mis-splicing of SMN2) was made. The same serine to alanine mutation was made in this construct as well (MGLRQ* and MGLRQ*S201A). B. Western blotting was used to determine protein levels of each of these SMN constructs, with expression driven by the endogenous promoter, in Drosophila S2 cells. Each of these SMN constructs (vSMN, vSMNΔ7S, and MGLRQ*) shows increased protein levels when the serine is mutated to an alanine, indicating disruption of the normal degradation of SMN. Additionally, MGLRQ* protein is present at higher levels than is vSMNΔ7S. Normalized fold change as compared to vSmn levels is indicated at the bottom. C. Flag-tagged SMN constructs were co-transfected with MycSlmb in Drosophila S2 cells. Protein lysates were Flag-immunoprecipitated and probed with anti-Myc antibody to detect SMN-Slmb interaction. In both full-length SMN (vSMN) . CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/078337 doi: bioRxiv preprint first posted online  and truncated SMN (vSMNΔ7), serine to alanine mutation decreased interaction of Slmb with SMN. Truncated SMN (vSMNΔ7) showed a dramatically increased interaction with Slmb as compared to full-length SMN (vSMN). . CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/078337 doi: bioRxiv preprint first posted online  
Intensity
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